Advertisement

Demystifying autoimmune inner ear disease

  • Soumyajit DasEmail author
  • Satvinder Singh Bakshi
  • Ramesh Seepana
Review Article
  • 21 Downloads

Abstract

Introduction

Autoimmune inner disease (AIED) is an uncommon cause of sensorineural hearing loss and poses a diagnostic challenge. The present study aims to review the existing knowledge on the clinicopathological aspects, the diagnostic challenges, and therapeutic interventions in AIED.

Discussion

The incidence of AIED is less than five cases per 100,000 population. There are no definite seromarkers which make diagnosis of AIED difficult. Even though various markers have been studied, their sensitivity and specificity have not been replicated in the clinical scenario. The treatment of the condition is also an enigma. Corticosteroids are the drug of choice and require long-term use to prevent relapse. Various other therapeutic agents have been studied in a small cohort of patients, but the efficacy of these drugs needs to be validated in a large multicentric trial.

Conclusion

Timely intervention can restore hearing loss in AIED patients, but the clinician has to find a delicate balance between the hearing outcome and the potential side effects resulting from long-term use of the drugs. Treatment of steroid resistant AIED is a challenge and there are no universal guidelines for the same. AIED being an uncommon diagnosis, multicentric trials and collaboration are required to formulate diagnostic criteria and therapeutic guidelines.

Keywords

Inner ear Autoimmunity Hearing loss Sensorineural Diagnosis Inner ear antigens Circulating antibodies Positron emission tomography Magnetic resonance imaging 

Notes

Funding

None.

Compliance with ethical standards

Conflict of interest

The author declares that they have no competing interests.

Research involving Human Participants and/or Animals

No human participant and/or animals were used in the study.

Informed consent

Not taken as no human participants were used in the study.

References

  1. 1.
    Vambutas A, Pathak S (2016) AAO: Autoimmune and autoinflammatory (Disease) in otology: what is new in immune-mediated hearing loss. Laryngoscope Investig Otolaryngol 1:110–115PubMedPubMedCentralCrossRefGoogle Scholar
  2. 2.
    Matsuoka AJ, Harris JP (2013) Autoimmune inner ear disease: a retrospective review of 47 patients. Audiol Neurotol 18:228–239CrossRefGoogle Scholar
  3. 3.
    Mijovic T (2013) Autoimmune sensorineural hearing loss: the otology rheumatology interface. Rheumatology 52:780–789PubMedCrossRefPubMedCentralGoogle Scholar
  4. 4.
    Schreiber BE, Agrup C, Haskard DO, Luxon LM (2010) Sudden sensorineural hearing loss. Lancet 375:1203–1211PubMedCrossRefPubMedCentralGoogle Scholar
  5. 5.
    Berrocal JRG, Ramirez-Camacho R (2002) Sudden sensorineural hearing loss: supporting the immunologic theory. Ann Otol Rhinol Laryngol 111:989–997PubMedCrossRefPubMedCentralGoogle Scholar
  6. 6.
    Wu CS, Lin HC, Chao PZ (2006) Sudden sensorineural hearing loss:evidence from taiwan. Audiol Neurotol 11:151–156CrossRefGoogle Scholar
  7. 7.
    Mathews J, Kumar BN (2003) Autoimmune sensorineural hearing loss. Clin Otolaryngol 28:479–488PubMedCrossRefPubMedCentralGoogle Scholar
  8. 8.
    Nordström CK, Danckwardt-Lillieström N, Laurell G, Liu W, Rask-Andersen H (2019) The human endolymphatic sac and inner ear immunity: macrophage interaction and molecular expression. Front Immunol.  https://doi.org/10.3389/fimmu.2018.03181 CrossRefGoogle Scholar
  9. 9.
    Li G, You D, Ma J, Li W, Sun S (2018) The role of autoimmunity in the pathogenesis of sudden sensorineural hearing loss. Neural Plast.  https://doi.org/10.1155/2018/7691473 (Article ID 7691473) CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Bovo R, Aimoni C, Martini A (2006) Immune mediated inner ear disease. Acta Otol 126:1012–1021CrossRefGoogle Scholar
  11. 11.
    Baek MJ, Park HM, Johnson JM, Altuntas CZ et al (2006) Increased frequencies of cochlin-specific T cells in patients with autoimmune sensorineural hearing loss. J Immunol 177:4203–4210PubMedCrossRefPubMedCentralGoogle Scholar
  12. 12.
    Lobo DR, García-Berrocal JR, Ramírez-Camacho R (2014) New prospects in the diagnosis and treatment of immune-mediated inner ear disease. World J Methodol 4(2):91–98PubMedPubMedCentralCrossRefGoogle Scholar
  13. 13.
    Chen YS, Emmerling O, Ilgner J, Westhofen M (2005) Idiopathic sudden sensorineural hearing loss in children. Int J Pediatr Otorhinolaryngol 69:817–821PubMedCrossRefPubMedCentralGoogle Scholar
  14. 14.
    Roman S, Aladio P, Paris J, Nicollas R (2001) Prognostic factors of sudden hearing loss in children. Int J Pediatr Otorhinolaryngol 61:17–21PubMedCrossRefPubMedCentralGoogle Scholar
  15. 15.
    Ciorba A, Corazzi V, Bianchini C, Aimoni C, Pelucci S et al (2018) Autoimmune inner ear disease(AIED): a diagnostic challenge. Int J Immunopathol Pharmacol 32:1–5CrossRefGoogle Scholar
  16. 16.
    Berrocal JRG, Ramirez-Camacho R, Millan I, Gorriz C et al (2003) Sudden presentation of immune-mediated inner ear disease: characterization and acceptance of a cochleovestibular dysfunction. J Laryngol Otol 117:775–779CrossRefGoogle Scholar
  17. 17.
    Shamriz O, Yuval T, Gross M (2018) Autoimmune inner ear disease: immune biomarkers, audiovestibular aspects, and therapeutic modalities of Cogan’s syndrome. J Immunol Res.  https://doi.org/10.1155/2018/1498640 (Article ID 1498640) CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Broughton SS, Meyerhoff WE, Cohen SB (2004) Immune-mediated inner ear disease: 10 year experience. Semin Arthritis Rheum 34:544–548PubMedCrossRefPubMedCentralGoogle Scholar
  19. 19.
    Girasoli L, Cazzador D, Padoan R, Nardello E et al (2018) Update on vertigo in autoimmune disorders, from diagnosis to treatment. J Immunol Res.  https://doi.org/10.1155/2018/5072582 CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Ralli M, D’Aguanno V, Stadio AD, Virgilio AD et al (2018) Audiovestibular symptoms in systemic autoimmune diseases. J Immunol Res.  https://doi.org/10.1155/2018/5798103 CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Khalessi A, Borghei P, Khalessi MH (2010) Autoimmune inner ear disease—a clinical viewpoint. Iran J Otorhinolaryngol 22(61):111–116Google Scholar
  22. 22.
    Rauch SD (1997) Clinical management of immune-mediated inner-ear disease. Ann N Y Acad Sci 830:203–210PubMedCrossRefPubMedCentralGoogle Scholar
  23. 23.
    Penêda JF, Lima NB, Monteiro F, Silva JV, Gama R, Condé A (2019) Immune-mediated inner ear disease: diagnostic and therapeutic approaches. Acta Otorrinolaryngol Esp 70(2):97–104CrossRefGoogle Scholar
  24. 24.
    Kohlert S, Bromwich M (2017) Mobile tablet audiometry in fluctuating autoimmune ear disease. J Otolaryngol Head Neck Surg 46(18):1–5Google Scholar
  25. 25.
    Ruckenstein MJ (2004) Autoimmune inner ear disease. Curr Opin Otolaryngol Head Neck Surg 12:426–430PubMedCrossRefPubMedCentralGoogle Scholar
  26. 26.
    Bonaguri C, Orsoni JG, Zavota L, Monica C et al (2007) Anti-68 kDa antibodies in autoimmune sensorineural hearing loss: are these autoantibodies really a diagnostic tool? Autoimmunity 40(1):73–78PubMedCrossRefPubMedCentralGoogle Scholar
  27. 27.
    El-Kabarity RH, El-Kabarity RH (2011) Diagnostic value of serum anti—heat shock Protein 70 (Anti-HSP70) in cases of autoimmune inner ear disease. Int Adv Otol 7(1):55–61Google Scholar
  28. 28.
    Ianuale C, Gabriella C, Feo ED, Liberati L et al (2013) A systematic review and meta-analysis of the diagnostic accuracy of anti-heat shock protein 70 antibodies for the detection of autoimmune hearing loss. Otol Neurotol 34:214–219PubMedCrossRefPubMedCentralGoogle Scholar
  29. 29.
    Moscicki RA, Martin JES, Quintero CH, Rauch SD, Nadol JB, Bloch KJ (1994) Serum antibody to inner ear proteins in patients with progressive hearing loss correlation With disease activity and response to corticosteroid treatment. JAMA 272:611–616PubMedCrossRefPubMedCentralGoogle Scholar
  30. 30.
    Bovo R, Ciorba A, Martini A (2009) The diagnosis of autoimmune inner ear disease: evidence and critical pitfalls. Eur Arch Otorhinolaryngol 266:37–40PubMedCrossRefPubMedCentralGoogle Scholar
  31. 31.
    Pham BN, Rudic M, Bouccara D, Sterkers O et al (2007) Antibodies to myelin protein zero (P0) protein as markers of auto-immune inner ear diseases. Autoimmunity 40(3):202–207PubMedCrossRefPubMedCentralGoogle Scholar
  32. 32.
    Cadoni G, Agostino S, Manna R, Santis AD et al (2003) Clinical Associations of Serum Antiendothelial Cell Antibodies in Patients With Sudden Sensorineural Hearing Loss. Laryngoscope 113:797–801PubMedCrossRefPubMedCentralGoogle Scholar
  33. 33.
    Boulassel MR, Tomasi JP, Deggouj N, Gersdorff M (2000) Identification of b-actin as a candidate autoantigen in autoimmune inner ear disease. Clin Otolaryngol 25:535–541PubMedCrossRefPubMedCentralGoogle Scholar
  34. 34.
    Yoo TJ, Tanaka H, Kwon SS, Mora F et al (2003) β-Tubulin as an autoantigen for autoimmune inner ear disease. Int Congr Ser 1240:1207–1210CrossRefGoogle Scholar
  35. 35.
    Zhang J, Wang N, Xu A (2019) miR-10b-3p, miR-8112 and let-7j as potential biomarkers for autoimmune inner ear diseases. Mol Med Rep. 20:171–181PubMedPubMedCentralGoogle Scholar
  36. 36.
    Zavod MB, Sataloff RT, Rao VM (2000) Frequency of Cochlear Enhancement on Magnetic Resonance Imaging in Patients With Autoimmune Sensorineural Hearing Loss. Arch Otolaryngol Head Neck Surg 126:969–971PubMedCrossRefPubMedCentralGoogle Scholar
  37. 37.
    Lobo D, Tuñón M, Villarreal I, Brea B, García-Berrocal JR (2018) Intratympanic gadolinium magnetic resonance imaging supports the role of endolymphatic hydrops in the pathogenesis of immune-mediated inner-ear disease. J Laryngol Otol 132:554–559PubMedCrossRefPubMedCentralGoogle Scholar
  38. 38.
    Mazlumzadeh M, Lowe VJ, Mullan BP, Fabry DA, McDonald TJ, Matteson EL (2003) The utility of positron emission tomography in the evaluation of autoimmune hearing loss. Otol Neurotol 24:201–204PubMedCrossRefPubMedCentralGoogle Scholar
  39. 39.
    Gupta R, Sataloff RT (2003) Noise induced autoimune sensorineural hearing loss. Ann Otol Rhinol Laryngol 112:569–573PubMedCrossRefPubMedCentralGoogle Scholar
  40. 40.
    Lasak JM, Sataloff RT, Hawkshaw M, Carey TE, Lyons KM, Spiegel JR (2001) Autoimmune inner ear disease: steroid and cytotoxic drug therapy. Ear Nose Throat J 808–11:815–816 (818 passim) Google Scholar
  41. 41.
    Berger P, Hillman M, Tabak M, Vollrath M (1991) The Lymphocyte transformation test with type II collagen as a diagnostic tool of autoimmune sensorineural hearing loss. Laryngoscope 101:895–899PubMedCrossRefPubMedCentralGoogle Scholar
  42. 42.
    Sismani A, Wise CM, Johnson GD (1997) Methotrexate management of immune- mediated cochleovestibular disorders. Otolaryngol Head Neck Surg 116:146–152CrossRefGoogle Scholar
  43. 43.
    Harris JP, Gopen Q, Kiethley E (2009) Autoimmune inner ear disease and other autoimmune diseases with inner ear involvement. In: Snow JB, Wackym PA (eds) Ballenger’s otorhinolaryngology head and neck surgery, 17th edn. BC Decker Inc., Connecticut, pp 305–312Google Scholar
  44. 44.
    Dietrich JB (2004) Endothelial cells of the blood-brain barrier: a target for glucocorticoids and estrogens? Front Biosci 9:684–693PubMedCrossRefPubMedCentralGoogle Scholar
  45. 45.
    Lee JH, Marcus DC (2002) Nongenomic effects of corticosteroids on ion transport by stria vascularis. Audiol Neurootol 7:100–106PubMedCrossRefPubMedCentralGoogle Scholar
  46. 46.
    Hughes GB, Kinney SE, Barna BP, Calabrese LH (1984) Practical versus theoritical management of autoimmune inner ear disease. Laryngoscope 94:758–767PubMedCrossRefPubMedCentralGoogle Scholar
  47. 47.
    Banerjee A, Parnes LS (2005) Intratympanic corticosteroids for sudden idiopathic sensorineural hearing loss. Otolo Neurotol 26:878–881CrossRefGoogle Scholar
  48. 48.
    Bird PA, Begg EJ, Zhang M, Keast AT, Murray DP, Balkany TJ (2007) Intratympanic versus intravenous delivery of methylprednisolone to cochlear perilymph. Otol Neurotol 28:1124–1130PubMedCrossRefPubMedCentralGoogle Scholar
  49. 49.
    Parnes LS, Sun AH, Freeman DJ (1999) Corticosteroid pharmacokinetics in the inner ear fluids: an animal study followed by clinical application. Laryngoscope 109:1–17PubMedCrossRefPubMedCentralGoogle Scholar
  50. 50.
    Berjis N, Soheilipour S, Musavi A, Hashemi SM (2016) Intratympanic dexamethasone injection vs methylprednisolone for the treatment of refractory sudden sensorineural hearing loss. Adv Biomed Res 5:111PubMedPubMedCentralCrossRefGoogle Scholar
  51. 51.
    García-Berrocal JR, Ibanez A, Rodriguez A, Gonzalez- Garcia JA et al (2006) Alternatives to systemic steroid therapy for refractory immune-mediated inner ear disease: a physiopathologic approach. Eur Arch Otorhinolaryngol 263:977–982PubMedCrossRefPubMedCentralGoogle Scholar
  52. 52.
    Sismanis A, Thompson T, Willis HE (1994) Methotrexate therapy for autoimmune hearing loss: a preliminary report. Laryngoscope 104:932–934PubMedPubMedCentralGoogle Scholar
  53. 53.
    Matteson EL, Fabry DA, Facer GW, Beatty CW et al (2001) Open trial of methotrexate as treatment for autoimmune hearing loss. Arthritis Care Res 45:146–150CrossRefGoogle Scholar
  54. 54.
    Harris J, Weisman M, Derebery J, Espeland M et al (2003) Treatment of corticosteroid-responsive autoimmune inner ear disease with methotrexate, a randomized controlled trial. JAMA 290:1875–1883PubMedCrossRefPubMedCentralGoogle Scholar
  55. 55.
    Brant JA, Eliades SJ, Ruckenstein MJ (2015) Systematic review of treatments for autoimmune inner ear disease. Otol Neurotol 36:1585–1592PubMedCrossRefPubMedCentralGoogle Scholar
  56. 56.
    Wijk FV, Staecker H, Keithley E, Lefebvre PP (2006) Local perfusion of the tumor necrosis factor α blocker infliximab to the inner ear improves autoimmune neurosensory hearing loss. Audiol Neurotol 11:357–365CrossRefGoogle Scholar
  57. 57.
    Cohen S, Shoup A, Weisman MH, Harris J (2005) Etanercept treatment for autoimmune inner ear disease: results of a pilot placebo-controlled study. Otol Neurotol 26:903–907PubMedCrossRefPubMedCentralGoogle Scholar
  58. 58.
    Pathak S, Goldofsky E, Vivas EX, Bonagura VR, Vambutas A (2011) IL-1β is overexpressed and aberrantly regulated in corticosteroid nonresponders with autoimmune inner ear disease. J Immunol 186:1870–1879PubMedPubMedCentralCrossRefGoogle Scholar
  59. 59.
    Cohen S, Roland P, Shoup A, Lowenstein M et al (2011) A pilot study of rituximab in immune-mediated inner ear disease. Audiol Neurotol 16:214–221CrossRefGoogle Scholar
  60. 60.
    Saraçaydin A, Katircioglu S, Katircioglu S, Karatay MC (1993) Azathioprine in combination with steroids in the treatment of autoimmune inner-ear disease. J Int Med Res 21:192–196PubMedCrossRefPubMedCentralGoogle Scholar
  61. 61.
    Luetje CM (1989) Theoritical and practical implications of plasmapheresis in autoimmune inner ear disease. Laryngoscope 99:1137–1146PubMedCrossRefPubMedCentralGoogle Scholar
  62. 62.
    Sakano Hitomi, Harris Jeffrey P (2018) Emerging options in immune-mediated hearing loss. Laryngoscope Investig Otolaryngol 4:102–108PubMedPubMedCentralCrossRefGoogle Scholar
  63. 63.
    Wang JR, Yuen HW, Shipp DB, Stewart S et al (2010) Cochlear implantation in patients with autoimmune inner ear disease including Cogan syndrome: a comparison with age- and sex-matched controls. Laryngoscope 120:2478–2483PubMedCrossRefPubMedCentralGoogle Scholar
  64. 64.
    Okano T (2014) Immune system of the inner ear as a novel therapeutic target for sensorineural hearing loss. Front Pharmacol 5:1–8CrossRefGoogle Scholar
  65. 65.
    Agrahari V, Agrahari V, Mitra AK (2017) Inner ear targeted drug delivery: what does the future hold? Ther Deliv. 8(4):179–184PubMedCrossRefPubMedCentralGoogle Scholar
  66. 66.
    Chien WW, Monzack EL, McDougald DS, Cunningham LL (2015) Gene therapy for sensorineural hearing loss. Ear Hear 36:1–7PubMedCrossRefPubMedCentralGoogle Scholar
  67. 67.
    Ra JC, Kang SK, Shin S, Park HG et al (2011) Stem cell treatment for patients with autoimmune disease by systemic infusion of culture-expanded autologous adipose tissue derived mesenchymal stem cells. J Transl Med 9:181PubMedPubMedCentralCrossRefGoogle Scholar
  68. 68.
    Lee MY, Park YH (2018) Potential of gene and cell therapy for inner ear hair cells. Biomed Res Int.  https://doi.org/10.1155/2018/8137614 CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Department of ENTAll India Institute of Medical SciencesMangalagiriIndia

Personalised recommendations